Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)

Rasha Abdelsalam Elshenawy

doi:10.57874/5kvv-sf51

Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)

Rasha Abdelsalam Elshenawy

School of Life and Medical Sciences

Research output: Other contribution

12 Downloads (Pure)

Abstract

"Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)" by R. Elshenawy provides a comprehensive analysis of antimicrobial use throughout the COVID-19 pandemic. This extensive four-year study focuses on antimicrobial stewardship (AMS) and antibiotic safety before and during the pandemic. Key phases include a systematic literature review, cross-sectional studies involving retrospective and prospective data, and preparation of detailed reports. The findings underscore significant shifts in antibiotic use, emphasising the need for robust AMS strategies to combat antimicrobial resistance (AMR). This report serves as a crucial resource for healthcare professionals, offering actionable recommendations to enhance AMS practices and ensure patient safety.

Original language	English
Type	Application
Publisher	Octopus
DOIs	https://doi.org/10.57874/5kvv-sf51
Publication status	Published - 13 May 2024

Keywords

Final report
Antimicrobial stewardship
Antibiotic resistance
antimicrobial resistance
Healthcare
PhD studies
hospitals
research project
Medication safety
patient safety
Quality Improvement
TECHNOLOGY
quality improvement
reporting
Systematic review
Retrospective Studies
Prospective Studies
research method
Pharmacist role
Acute care setting

Access to Document

10.57874/5kvv-sf51Licence: CC BY

Final_Version
Published on Octopus. This is an open access work distributed under the terms of the Creative Commons Attribution License (CC BY), https://creativecommons.org/licenses/by/4.0/
Final published version, 1 MBLicence: CC BY

Cite this

@misc{7f4255904c8e4cda92394cf9a642354e,

title = "Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)",

abstract = "{"}Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024){"} by R. Elshenawy provides a comprehensive analysis of antimicrobial use throughout the COVID-19 pandemic. This extensive four-year study focuses on antimicrobial stewardship (AMS) and antibiotic safety before and during the pandemic. Key phases include a systematic literature review, cross-sectional studies involving retrospective and prospective data, and preparation of detailed reports. The findings underscore significant shifts in antibiotic use, emphasising the need for robust AMS strategies to combat antimicrobial resistance (AMR). This report serves as a crucial resource for healthcare professionals, offering actionable recommendations to enhance AMS practices and ensure patient safety.",

keywords = "Final report, Antimicrobial stewardship, Antibiotic resistance, antimicrobial resistance, Healthcare, PhD studies, hospitals, research project, Medication safety, patient safety, Quality Improvement, TECHNOLOGY, quality improvement, reporting, Systematic review, Retrospective Studies, Prospective Studies, research method, Pharmacist role, Acute care setting",

author = "{Abdelsalam Elshenawy}, Rasha",

note = "Published on Octopus. This is an open access work distributed under the terms of the Creative Commons Attribution License (CC BY), https://creativecommons.org/licenses/by/4.0/ ",

year = "2024",

month = may,

day = "13",

doi = "10.57874/5kvv-sf51",

language = "English",

publisher = "Octopus",

type = "Other",

}

TY - GEN

T1 - Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)

AU - Abdelsalam Elshenawy, Rasha

N1 - Published on Octopus. This is an open access work distributed under the terms of the Creative Commons Attribution License (CC BY), https://creativecommons.org/licenses/by/4.0/

PY - 2024/5/13

Y1 - 2024/5/13

N2 - "Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)" by R. Elshenawy provides a comprehensive analysis of antimicrobial use throughout the COVID-19 pandemic. This extensive four-year study focuses on antimicrobial stewardship (AMS) and antibiotic safety before and during the pandemic. Key phases include a systematic literature review, cross-sectional studies involving retrospective and prospective data, and preparation of detailed reports. The findings underscore significant shifts in antibiotic use, emphasising the need for robust AMS strategies to combat antimicrobial resistance (AMR). This report serves as a crucial resource for healthcare professionals, offering actionable recommendations to enhance AMS practices and ensure patient safety.

AB - "Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)" by R. Elshenawy provides a comprehensive analysis of antimicrobial use throughout the COVID-19 pandemic. This extensive four-year study focuses on antimicrobial stewardship (AMS) and antibiotic safety before and during the pandemic. Key phases include a systematic literature review, cross-sectional studies involving retrospective and prospective data, and preparation of detailed reports. The findings underscore significant shifts in antibiotic use, emphasising the need for robust AMS strategies to combat antimicrobial resistance (AMR). This report serves as a crucial resource for healthcare professionals, offering actionable recommendations to enhance AMS practices and ensure patient safety.

KW - Final report

KW - Antimicrobial stewardship

KW - Antibiotic resistance

KW - antimicrobial resistance

KW - Healthcare

KW - PhD studies

KW - hospitals

KW - research project

KW - Medication safety

KW - patient safety

KW - Quality Improvement

KW - TECHNOLOGY

KW - quality improvement

KW - reporting

KW - Systematic review

KW - Retrospective Studies

KW - Prospective Studies

KW - research method

KW - Pharmacist role

KW - Acute care setting

U2 - 10.57874/5kvv-sf51

DO - 10.57874/5kvv-sf51

M3 - Other contribution

PB - Octopus

ER -

Final Report: Real Approaches to the Study of Antimicrobials During the Pandemic (2020-2024)

Abstract

Keywords

Access to Document

Fingerprint

Cite this